Which analysis would help determine the option providing the greatest number of immunizations at the least cost?

The selection of cost-effectiveness analysis as the correct choice for determining the option that provides the greatest number of immunizations at the least cost is grounded in its specific focus on comparing the relative costs and outcomes of different interventions. Cost-effectiveness analysis evaluates the costs associated with each intervention relative to their effectiveness, which in this context, translates to the number of immunizations administered.

This type of analysis allows health educators and policymakers to make informed decisions by identifying which method of delivering immunizations provides the most value for the investment made. It takes into consideration not only the monetary costs but also the effectiveness in terms of health outcomes, making it particularly useful for healthcare interventions where the goal is to maximize health benefits within limited budgets.

While cost-benefit analysis also looks at costs, it quantifies both costs and benefits in monetary terms, making it less applicable when the primary concern is the number of immunizations rather than financial returns. Cost utility analysis incorporates quality-adjusted life years (QALYs) or similar metrics, making it more suited for comparing health outcomes with different interventions but not specifically aimed at maximizing immunizations. Cost verification analysis does not pertain directly to effectiveness or outcomes but rather focuses on ensuring that the costs reported are accurate and justified.

In contexts where the